Document is current

Article History

Received: 31 January 2025

Revised: 26 March 2025

Accepted: 26 March 2025

First Online: 9 April 2025

Declarations

:

: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee (IRCCS Istituto Oncologico “Gabriella Serio”) and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.

: Informed consent was obtained from all individual participants included in the study.

: • Monica Amendolara reported no conflicts of interest.• Valentina Di Lecce reported no conflicts of interest.• Vitaliano Nicola Quaranta reported no conflicts of interest.• Carla Santomasi support for attending meetings and/or travel from Avenue Media, Mediabout, GlaxoSmithKline.• Andrea Portacci reported payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing or educational events from Astrazeneca, GlaxoSmithKline, Chiesi, Sanofi, Zambon.• Ilaria Dei Lazzaretti reported no conflicts of interest.• Laura Anna Sara Cuccaro reported no conflicts of interest.• Massimo Casparrini reported no conflicts of interest.• Sebastiano Spierto reported no conflicts of interest.• Vito Picerno reported no conflicts of interest.• Cristina De Robertis reported no conflicts of interest.• Sara Quaranta reported no conflicts of interest.• Silvano Dragonieri reported no conflicts of interest.• Giovanna Elisiana Carpagnano reported grants or contracts from Astrazeneca, Chiesi, GlaxoSmithKline, Sanofi, Grifols; payment or honoraria for lectures, presentations, speakers, bureaus, manuscript writing or educational events from Astrazeneca, GlaxoSmithKline, Sanofi; support for attending meetings and/or travel from Astrazeneca, Menarini, Chiesi.